NCT04634136 (HemPhar) is a NA clinical trial of Lab tests in Children, Adult, sponsored by University Medical Centre Ljubljana.

Who is sponsoring NCT04634136?

NCT04634136 is sponsored by University Medical Centre Ljubljana.

What drugs are being tested in NCT04634136?

Interventions in NCT04634136: Lab tests, ECG, Cannabinoid Levels, Full-spectrum Medical Canabis Product (HemPhar), Placebo, Spasticity level according to modified Ashworth scale (Bohannon), Gross Motor Function Measure, Borg rating of perceived exertion scale, Edmonton symptom assessment system.

What condition does NCT04634136 study?

NCT04634136 studies Children, Adult, Spastic Cerebral Palsy, Quality of Life, Cannabis, Physical Disability.

Is NCT04634136 still recruiting?

NCT04634136 is currently completed. Last updated 22 May 2024.

Last reviewed 2024-05-22 · How we verify

NCT04634136: HemPhar

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy

Completed NA Last updated 22 May 2024

What this trial tests

NA trial testing Lab tests in Children, Adult in 55 participants. Completed in 29 February 2024.

Timeline

15 October 2020

Primary endpoint
1 December 2023

29 February 2024

Quick facts

Lead sponsor	University Medical Centre Ljubljana
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	55
Start date	15 October 2020
Primary completion	1 December 2023
Estimated completion	29 February 2024
Sites	2 locations across Slovenia

Drugs / interventions tested

Lab tests
ECG
Cannabinoid Levels
Full-spectrum Medical Canabis Product (HemPhar) — full drug profile →
Placebo
Spasticity level according to modified Ashworth scale (Bohannon)
Gross Motor Function Measure
Borg rating of perceived exertion scale
Edmonton symptom assessment system

Conditions studied

Children, Adult — all drugs for Children, Adult →
Spastic Cerebral Palsy — all drugs for Spastic Cerebral Palsy →
Quality of Life — all drugs for Quality of Life →
Cannabis — all drugs for Cannabis →

Sponsor

University Medical Centre Ljubljana

Who can join

Adults 5 to 25, any sex, with Children, Adult or Spastic Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study is a double-blind, placebo-controlled, cross over study on 60 children aged 5 to 25 years with severe spasticity related to cerebral palsy (CP), level IV and V with full-spectrum medical cannabis product of CBD/THC ratio 10:1.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Medical Cannabis in Pediatric Oncology: Friend or Foe?
Malach M, Kovalchuk I, Kovalchuk O. · · 2022 · cited 8× · PMID 35337156 · DOI 10.3390/ph15030359

Verify or expand the search:

Other recruiting trials for Children, Adult

Currently open trials in the same condition.

NCT07248475 — Effects of Battle Rope Training on ROM and Pain in Children With Post Traumatic Elbow Contractures. · NA · recruiting
NCT07244107 — Agility and Sprint Performance in Youth Soccer: A Comparison of FIFA 11+ and RAMP Protocols · NA · recruiting
NCT06544824 — Accuracy Comparison: Optoelectronic Motion Capture and Markerless System · active not recruiting
NCT05629013 — TEAMS R34 #1 After-Action Reviews in Child Welfare Services · NA · recruiting
NCT05055830 — Opportunistic PK/PD Trial in Critically Ill Children (OPTIC) · recruiting

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04634136 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
Last refreshed: 22 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04634136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing